Journal article
Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease
Abstract
BACKGROUND AND OBJECTIVES: Potential cost and effectiveness of a nephrologist/nurse-based multifaceted intervention for stage 3 to 4 chronic kidney disease are not known. This study examines the cost-effectiveness of a chronic disease management model for chronic kidney disease.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Cost and cost-effectiveness were prospectively gathered alongside a multicenter trial. The Canadian Prevention of Renal …
Authors
Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ
Journal
Clinical Journal of the American Society of Nephrology, Vol. 6, No. 6, pp. 1248–1257
Publisher
Wolters Kluwer
Publication Date
6 2011
DOI
10.2215/cjn.07180810
ISSN
1555-9041
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedBiomarkersCanadaCardiovascular AgentsCardiovascular DiseasesChronic DiseaseCost SavingsCost-Benefit AnalysisCreatinineDisease ProgressionDrug CostsFemaleGeneral PracticeGlomerular Filtration RateHealth Care CostsHematinicsHospital CostsHospitalizationHumansHypoglycemic AgentsHypolipidemic AgentsKidneyKidney DiseasesLength of StayMaleMiddle AgedModels, EconomicNurse CliniciansPatient Care TeamPlatelet Aggregation InhibitorsPreventive Health ServicesProspective StudiesQuality-Adjusted Life YearsRisk AssessmentRisk FactorsRisk Reduction BehaviorSeverity of Illness IndexSmoking CessationTime FactorsTreatment OutcomeUp-Regulation